Differential synergistic effects of palbociclib and doxorubicin on doxorubicin-resistant cancer cells with diverse tumor origins-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Differential synergistic effects of palbociclib and doxorubicin on doxorubicin-resistant cancer cells with diverse tumor origins

Published:2024-04-25 Issue: Volume: Page:1-9
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Yalcin Gizem Damla¹,Mutlu Pelin²,Kazan Hasan Huseyin³⁴,Gunduz Ufuk¹

Affiliation:

1. Department of Biological Sciences, Middle East Technical University, Ankara, Turkiye

2. Department of Biotechnology, Biotechnology Institute, Ankara University, Ankara, Turkiye

3. Department of Medical Genetics, Faculty of Medicine, Near East University, Nicosia, Turkiye

4. DESAM Institute, Near East University, Nicosia, Turkiye

Funder

Scientific and Technical Research Council of Turkey

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2024.2345454

Reference43 articles.

1. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

2. Mechanisms of therapeutic CDK4/6 inhibition in breast cancer

3. Palbociclib: A Review in HR-Positive, HER2-Negative, Advanced or Metastatic Breast Cancer

4. Novel Strategies in Hormone Receptor-Positive Advanced Breast Cancer: Overcoming Endocrine Resistance

5. Molecular mechanisms of drug resistance

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP